Gina Ma

First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial

Fang Liu, Yuanzhen Cao, Kevin G. Pinz et al. · Blood · 2018 · 137 citations

Targeting T Cell Malignancies Using CD4CAR T-Cells and Implementing a Natural Safety Switch

Gina Ma, Jiaqi Shen, Kevin G. Pinz et al. · Stem Cell Reviews and Reports · 2019 · 58 citations

Cell Therapy, Natural Safety Switch, Cancer Immunosurveillance +6

Setd1a and NURF mediate chromatin dynamics and gene regulation during erythroid lineage commitment and differentiation

Ying Li, Vincent Schulz, Changwang Deng et al. · Nucleic Acids Research · 2016 · 51 citations · Full text

Genetics, Erythroid Lineage Commitment, Epigenetics +19

Expansion of hematopoietic stem cells for transplantation: current perspectives

Jessica A. Schuster, Maria R Stupnikov, Gina Ma et al. · Experimental Hematology and Oncology · 2012 · 35 citations · Full text

Cell Therapy, Immunology, Cell Replacement Therapy +17

Anti-CD19 chimeric antigen receptor targeting of CD19 + acute myeloid leukemia

Gina Ma, Yi Wang, Tahmeena Ahmed et al. · Leukemia Research Reports · 2018 · 18 citations · Full text